| 1 | Budd-Chiari syndrome in myeloproliferative neoplasms:A review of literature显示文摘Myeloproliferative neoplasms(MPNs)are defined as clonal disorders of the hematopoietic stem cell in which an exaggerated production of terminally differentiated myeloid cells occurs.Classical,Philadelphia-negative MPNs,i.e.,polycythemia vera,essential thrombocythemia and primary myelofibrosis,exhibit a propensity towards the development of thrombotic complications that can occur in unusual sites,e.g.,portal,splanchnic or hepatic veins,the placenta or cerebral sinuses.The pathogenesis of thrombotic events in MPNs is complex and requires an intricate mechanism involving endothelial injury,stasis,elevated leukocyte adhesion,integrins,neutrophil extracellular traps,somatic mutations(e.g.,the V617F point mutation in the JAK2 gene),microparticles,circulating endothelial cells,and other factors,to name a few.Herein,we review the available data on Budd-Chiari syndrome in Philadelphia-negative MPNs,with a particular focus on its epidemiology,pathogenesis,histopathology,risk factors,classification,clinical presentation,diagnosis,and management. | Mihnea-Alexandru Găman Matei-Alexandru Cozma Muhammad Romail Manan Bahadar S Srichawla Arkadeep Dhali Sajjad Ali Ahmed Nahian Andrew C Elton L V Simhachalam Kutikuppala Richard Christian Suteja Sebastian Diebel Amelia Maria Găman Camelia Cristina Diaconu | 2023 | World Journal of Clinical Oncology2023，14，3： | 0 |
| 2 | Acute myocardial infarction in myeloproliferative neoplasms显示文摘Myeloproliferative neoplasms(MPNs)are a heterogeneous group of hematologic malignancies characterized by an abnormal proliferation of cells of the myeloid lineage.Affected individuals are at increased risk for cardiovascular and thrombotic events.Myocardial infarction(MI)may be one of the earliest clinical manifestations of MPNs or may be a thrombotic complication that develops during the natural course of the disease.In the present review,we examine the epidemiology,pathogenesis,clinical presentation,and management of MI in MPNs based on the available literature.Moreover,we review potential biomarkers that could mediate the MI-MPNs crosstalk,from classical biochemical tests,e.g.,lactate dehydrogenase,creatine kinase and troponins,to pro-inflammatory cytokines,oxidative stress markers,and clonal hematopoiesis. | Muhammad Romail Manan Vincent Kipkorir Iqra Nawaz Maryann Wanjiku Waithaka Bahadar Singh Srichawla Amelia Maria Găman Camelia Cristina Diaconu Mihnea-Alexandru Găman | 2023 | World Journal of Cardiology2023，15，11： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员